Immunoglobulin Replacement Therapy Guidelines for Antibody Deficiency

Diagnostic Criteria and Indications

The American Academy of Allergy, Asthma, and Immunology recommends that normal total IgG levels are a critical exclusion criterion for standard immunoglobulin replacement therapy 1, 2, 3
Patients with asymptomatic hypogammaglobulinemia and normal antibody responses, or those with normal IgG levels, are classified as Category F, where immunoglobulin replacement is not indicated 3, 4
The American Academy of Allergy, Asthma, and Immunology guidelines explicitly warn that too many healthy subjects are being administered an expensive treatment for which there is no documented need when patients present with recurrent infections but normal or borderline IgG levels 1, 2

Immunoglobulin replacement for selective antibody deficiency is classified as Category C1, where antibiotic prophylaxis might be equally effective 4, 5
The American Academy of Allergy, Asthma, and Immunology states that for patients with selective IgA deficiency and similar conditions, the majority of these patients will have minimal clinical response to IgG replacement 6, 7
IgG replacement in specific antibody deficiency should only be considered as a last resort after aggressive antibiotic therapy and prophylaxis have failed 6, 8

The American Academy of Allergy, Asthma, and Immunology recommends aggressive antimicrobial therapy and prophylactic antibiotics for recurrent sinopulmonary infections as a first-line approach before considering immunoglobulin replacement 6, 7
Treat underlying atopic disease aggressively if present, as allergic inflammation predisposes to respiratory infections 6, 7
Review medication history, as certain drugs can cause secondary antibody deficiency 6, 7

Hypogammaglobulinemia defined as significant reduction in ≥2 isotypes, not borderline values, is a criterion that would justify immunoglobulin replacement 1, 2, 3
Documented severe or recurrent infections negatively affecting quality of life, plus failure of aggressive antibiotic therapy/prophylaxis, is another criterion that would justify immunoglobulin replacement 6, 7, 8

The placebo effect is substantial, and passive immunization with immunoglobulin at regular intervals might be credited as a miraculous recovery, reminding physicians that the placebo effect is hard to argue against 1, 2, 10
Resource stewardship concerns, as without carefully controlled clinical trials demonstrating benefit in this population, immunoglobulin use might result in significant and inappropriate expenditures 1, 2, 3